Both in Pharmaceuticals
Arbutus Biopharma vs Collegium Pharmaceutical
Over the past year ABUS returned −10.0% and COLL returned −33.7%; their daily moves had a correlation of 0.16.
ABUS −10.0% COLL −33.7%Growth of $1, one year, split-adjusted
| Metric | ABUS | COLL |
|---|---|---|
| Price | $4.05 | $23.71 |
| Market cap | $802.3M | $771.9M |
| Today | +4.38% | −0.08% |
| 1 month | −9.6% | +8.4% |
| 6 months | −8.4% | −35.1% |
| Year to date | −15.8% | −48.8% |
| 1 year | −11.6% | −34.3% |
| Revenue growth (YoY) | −90.6% | +6.3% |
| Gross margin | 100.0% | 86.7% |
| Net margin | −512.0% | −7.5% |
| P/E (TTM) | 5.2× | 16.1× |
| Price / sales | 4.4× | 1.0× |
| Net cash | $89.5M | -$962.1M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 33.9% |
| Short % of float | 15.6% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).